Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHABLIS-T: Tenecteplase for Acute Ischemic Stroke (4.5-24h)
NCT04086147Phase 2Completed
- Sponsor
- Huashan Hospital
- Start
- Dec 2019
- Primary completion
- Dec 2021
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of tenecteplase in ischemic stroke, sponsored by Huashan Hospital. Started Dec 2019; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04086147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04086147.